Global Business Enterprise R&D Expenditure in Human Health Activities by Country

In 2023, Italy led in R&D expenditure in human health activities with $431.08 million, seeing a modest 3.48% growth. Israel and Taiwan followed, both showing solid growth figures, with Israel specifically marking a 4.16% increase. The United Kingdom and Poland exhibited notable increases of 9.12% and 9.63%, respectively. Remarkably, Romania grew its expenditure by 87.61%, albeit from a lower base. Other countries like Germany and New Zealand maintained steady levels without growth in 2023.

Looking ahead, countries that experienced recent surges, like Romania and Lithuania with its 21.4% increase, could continue this trend if sustained investment and innovation policies are maintained. Observers should also monitor emerging markets and smaller economies that might ramp up their R&D investments in trying to catch up with technologically advanced nations.

Top countries in Business Enterprise R&D Expenditure in Human Health Activities by Country

# 10 Countries Million US Dollars PPP = 2015 Last Year YoY 5-years CAGR
1 1 Italy 431.08 2023 +5.48% +3.48% View data
2 2 Israel 345.07 2023 +3.71% +4.16% View data
3 3 Taiwan 311.89 2023 +2.78% +2.09% View data
4 4 Spain 122.02 2023 +2.38% +0.6% View data
5 5 United Kingdom 111.62 2023 +4.34% +9.12% View data
6 6 Poland 52.01 2023 +8.34% +9.63% View data
7 7 Portugal 49.87 2023 +15.79% +20.4% View data
8 8 South Korea 38.81 2023 +5.5% +18.96% View data
9 9 New Zealand 34.46 2023 +6.92% View data
10 10 Finland 21.07 2021 +55.05% View data

Top Countries about Research And Development